RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review.

SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review.

Add to Collection
2019 Feb 15 Systematic Review and Meta Analysis H Raj, H Durgia, R Palui, S Kamalanathan… - … journal of diabetes, 2019 - ncbi.nlm.nih.gov

Full Author : ['Raj, Henith', 'Durgia, Harsh', 'Palui, Rajan', 'Kamalanathan, Sadishkumar', 'Selvarajan, Sandhiya', 'Kar, Sitanshu Sekhar', 'Sahoo, Jayaprakash']
Journal Title : World journal of diabetes
Chapter : Section4
Journal Year : 2019
Cited by : 64

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a common comorbidity with type 2 diabetes. The existing therapeutic options for NAFLD are not adequate. Hypocaloric diet and exercise is the cornerstone of therapy in NAFLD. Pioglitazone is the only..... Read More

Keywords : ['nonalcoholic fatty liver disease patient', 'type diabetes mellitus', 'systematic review', 'inhibitor']
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379733/
Google Scholar Link : https://scholar.google.com/scholar?cites=10209568032705479593&as_sdt=5,33&sciodt=0,33&hl=en&num=20